EOD one day will be much higher ....hmmmm, especially when this Jersey boy below sees the full potential behind PS Targeting and all that will be discovered
"Jeff Boschwitz
Jeff Boschwitz, Ph.D., NMG consultant, is a healthcare executive with a strong scientific and business background. He has consistently developed and executed game-changing ideas to drive business to the next level of performance while improving health outcomes and reducing costs.
Dr. Boschwitz is well versed in strategic planning, growth strategy development, new product planning, due diligence for product licensing and commercialization strategy. He also has experience with post-merger integration planning, laboratory operations process re-engineering and improvements, and laboratory build-outs.
Prior to joining NMG, Dr. Boschwitz was Chief Operating Office of Personal Genome Diagnostics, a cancer genomics start-up spun out of Johns Hopkins University. He also served as Executive Vice President of Operations for PLUS Diagnostics, Vice President of Sales and Marketing for Orchid Cellmark and Director of Market Research, Planning, and Analysis for Quest Diagnostics.
Dr. Boschwitz has a B.S. In biology and Ph.D. In Immunology from Cornell University and completed his post-doctoral fellowship at Stanford University.
Dr. Boschwitz resides in New Jersey with his family."